NL7207663A - - Google Patents

Info

Publication number
NL7207663A
NL7207663A NL7207663A NL7207663A NL7207663A NL 7207663 A NL7207663 A NL 7207663A NL 7207663 A NL7207663 A NL 7207663A NL 7207663 A NL7207663 A NL 7207663A NL 7207663 A NL7207663 A NL 7207663A
Authority
NL
Netherlands
Application number
NL7207663A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7207663A publication Critical patent/NL7207663A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7207663A 1971-06-18 1972-06-06 NL7207663A (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15459371A 1971-06-18 1971-06-18
US20753871A 1971-12-13 1971-12-13

Publications (1)

Publication Number Publication Date
NL7207663A true NL7207663A (cg-RX-API-DMAC10.html) 1972-12-20

Family

ID=26851578

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7207663A NL7207663A (cg-RX-API-DMAC10.html) 1971-06-18 1972-06-06

Country Status (12)

Country Link
JP (1) JPS5317599B1 (cg-RX-API-DMAC10.html)
CA (1) CA989390A (cg-RX-API-DMAC10.html)
CH (1) CH578574A5 (cg-RX-API-DMAC10.html)
DD (1) DD100003A5 (cg-RX-API-DMAC10.html)
DE (1) DE2264753C3 (cg-RX-API-DMAC10.html)
DK (1) DK138652B (cg-RX-API-DMAC10.html)
ES (1) ES403864A1 (cg-RX-API-DMAC10.html)
FR (1) FR2142003B1 (cg-RX-API-DMAC10.html)
GB (1) GB1377704A (cg-RX-API-DMAC10.html)
NL (1) NL7207663A (cg-RX-API-DMAC10.html)
PL (1) PL86959B1 (cg-RX-API-DMAC10.html)
SE (1) SE400562B (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114276368B (zh) * 2021-12-23 2023-12-26 山东鑫泉医药有限公司 他唑巴坦二苯甲酯的合成方法

Also Published As

Publication number Publication date
DE2264753C3 (de) 1982-03-11
DE2229246A1 (de) 1973-01-04
DE2264753A1 (de) 1975-01-09
DD100003A5 (cg-RX-API-DMAC10.html) 1973-09-05
DK138652C (cg-RX-API-DMAC10.html) 1979-04-30
ES403864A1 (es) 1975-12-16
CH578574A5 (cg-RX-API-DMAC10.html) 1976-08-13
DE2229246B2 (de) 1976-12-30
FR2142003A1 (cg-RX-API-DMAC10.html) 1973-01-26
CA989390A (en) 1976-05-18
FR2142003B1 (cg-RX-API-DMAC10.html) 1976-03-05
JPS5317599B1 (cg-RX-API-DMAC10.html) 1978-06-09
GB1377704A (en) 1974-12-18
DE2264753B2 (de) 1981-02-19
DK138652B (da) 1978-10-09
PL86959B1 (en) 1976-06-30
SE400562B (sv) 1978-04-03

Similar Documents

Publication Publication Date Title
FR2122505A1 (cg-RX-API-DMAC10.html)
CS166809B2 (cg-RX-API-DMAC10.html)
FI53103B (cg-RX-API-DMAC10.html)
DK131012C (cg-RX-API-DMAC10.html)
FR2122006A5 (cg-RX-API-DMAC10.html)
FR2123311A1 (cg-RX-API-DMAC10.html)
DK133390C (cg-RX-API-DMAC10.html)
FR2121955A5 (cg-RX-API-DMAC10.html)
DK138652C (cg-RX-API-DMAC10.html)
FR2123159A3 (cg-RX-API-DMAC10.html)
CS158990B1 (cg-RX-API-DMAC10.html)
CS151771B1 (cg-RX-API-DMAC10.html)
DE2105114A1 (cg-RX-API-DMAC10.html)
DE2157503A1 (cg-RX-API-DMAC10.html)
DE2106558A1 (cg-RX-API-DMAC10.html)
DE7137570U (cg-RX-API-DMAC10.html)
CS165472B1 (cg-RX-API-DMAC10.html)
CS155759B1 (cg-RX-API-DMAC10.html)
CH579145A5 (cg-RX-API-DMAC10.html)
DD98281A5 (cg-RX-API-DMAC10.html)
CH545714A (cg-RX-API-DMAC10.html)
DD96986A1 (cg-RX-API-DMAC10.html)
BG19880A1 (cg-RX-API-DMAC10.html)
CH563413A5 (cg-RX-API-DMAC10.html)
BG17136A1 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
BC A request for examination has been filed
BV The patent application has lapsed